Valuation: Haleon plc

Market Cap 32.88B 44.21B 38.67B 35.74B 61.98B 4,259B 63.36B 426B 167B 2,085B 166B 162B 7,185B P/E 2026 *
19.3x
P/E 2027 * 17.5x
Enterprise Value 39.8B 53.51B 46.8B 43.25B 75.02B 5,155B 76.68B 516B 202B 2,523B 201B 196B 8,695B EV / Sales 2026 *
3.49x
EV / Sales 2027 * 3.3x
Free-Float
99.42%
Yield 2026 *
2.14%
Yield 2027 * 2.38%
1 day+0.86%
1 week+3.18%
Current month+7.36%
1 month+11.83%
3 months+4.10%
6 months+2.58%
Current year-0.40%
1 week 354.1
Extreme 354.1
377.5
1 month 329.3
Extreme 329.3
377.5
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Buy 24,891 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.86%+3.18%+4.07%+18.04% 44.24B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average +0.02%+0.80%+26.09%+50.32% 361.93B
Weighted average by Cap. +0.38%+0.06%+37.10%+78.88%

Financials

2026 *2027 *
Net sales 11.4B 15.33B 13.4B 12.39B 21.49B 1,476B 21.96B 148B 57.75B 723B 57.54B 56.26B 2,491B 11.89B 15.99B 13.98B 12.92B 22.41B 1,540B 22.91B 154B 60.24B 754B 60.02B 58.69B 2,598B
Net income 1.74B 2.34B 2.05B 1.89B 3.29B 226B 3.36B 22.59B 8.83B 110B 8.8B 8.6B 381B 1.9B 2.56B 2.24B 2.07B 3.58B 246B 3.66B 24.64B 9.63B 121B 9.6B 9.38B 415B
Net Debt 6.91B 9.3B 8.13B 7.51B 13.03B 896B 13.32B 89.62B 35.02B 438B 34.9B 34.13B 1,511B 6.4B 8.61B 7.53B 6.96B 12.07B 830B 12.34B 83.01B 32.44B 406B 32.33B 31.61B 1,399B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-17 GBX 373.30 +0.86% 20,562,834
26-07-16 GBX 370.10 +3.03% 17,624,000
26-07-15 GBX 359.20 -0.31% 22,047,851
26-07-14 GBX 360.30 -1.29% 11,985,968
26-07-13 GBX 365.00 +0.88% 10,734,999
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.733GBP
Average target price
4.142GBP
Spread / Average Target
+10.97%

Quarterly revenue - Rate of surprise